ArticleJournal of gynecologic oncology2025

HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma.

Chiharu Mizoguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.